Reuters logo
BRIEF-Buffalo Capital says Waverly Pharma's unit entered deal to sell 2 generic cancer drugs
September 15, 2017 / 4:13 PM / 2 months ago

BRIEF-Buffalo Capital says Waverly Pharma's unit entered deal to sell 2 generic cancer drugs

Sept 15 (Reuters) - Buffalo Capital Inc:

* Buffalo Capital Inc. announces mailing of information circular and provides transaction update

* Buffalo Capital says ‍ Waverley Pharma International has entered a License, Manufacture and Supply Agreement with Reliance Life Sciences Private Limited​

* Buffalo Capital Inc says ‍ pursuant to agreement, WPI acquired non-exclusive license to market, sell and distribute WAV-101 and WAV-102 in United Kingdom​

* Buffalo Capital says ‍pursuant to agreement, WPI acquired exclusive license to market,sell,distribute WAV-101 and WAV-102, in U.S.,Canada,European Union​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below